IP Library Granted Patent US 8,008,308
Granted Patent B2
US 8,008,308 · App. 12/701,410 · Granted Aug 30, 2011

Phosphonate compounds

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,008,308
App. No.
12/701,410
Granted
Aug 30, 2011
Kind
B2
Abstract

The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.

Claims (19)

1. An antiviral compound having the following structure:

or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition comprising an effective amount of the antiviral compound of

in combination with a pharmaceutically acceptable carrier.

3. The pharmaceutical composition of claim 2 is in a solid dosage form.

4. The pharmaceutical composition of claim 2 is in a capsule, tablet, aerosol, solution, suspension, or in a topical formulation.

5. A method for the treatment of a viral disease comprising administering an effective amount of the antiviral compound having the structure of

or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.

6. The method of claim 5 , wherein the viral disease is selected from the group consisting of human immunodeficiency virus, influenza, herpes simplex virus, human herpes virus, cytomegalovirus, hepatitis B and C virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus.

7. The method of claim 6 , wherein the orthopox is selected from variola major and minor, vaccinia, smallpox, cowpox, camelpox and monkeypox.

8. The method of claim 5 , wherein the virus is HIV.

9. The method of claim 5 , wherein the virus is influenza.

10. The method of claim 5 , wherein the virus is herpes.

11. The method of claim 5 , wherein the virus is cytomegalovirus.

12. The method of claim 5 , wherein the virus is hepatitis B.

13. The method of claim 5 , wherein the virus is hepatitis C.

14. The method of claim 5 , wherein the virus is Epstein-Barr virus.

15. The method of claim 5 , wherein the virus is varicella zoster virus.

16. The method of claim 5 , wherein the virus is papilloma.

Continuity (9)
Continuation 11925309 · Oct 26, 2007
Continuation 11715604 · Mar 7, 2007
Continuation 11506292 · Aug 17, 2006
Continuation 11100882 · Apr 6, 2005
Continuation 10759345 · Jan 15, 2004
Continuation 10148374
Provisional Application 60205179 · May 17, 2000
Provisional Application 60168813 · Dec 3, 1999
Related Publication 20100173870A1 · Jul 8, 2010